Our results show a significant 1.5-fold (p = 0.0098) increase and a 2.5-fold (p = 0.0134) increase in the β-F1-ATPase/GAPDH ratio in WT mice and Apex1+/− mice, respectively, after AOM treatment (Figure 2; original image can be found in Figure S1). The gene discussed is APEX1; the disease is infectious otitis media.